• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Medicines Co/The

+ Add to Watchlist

MDCO:US

24.0900 USD 0.5400 2.29%

As of 20:10:00 ET on 07/30/2014.

Snapshot for Medicines Co/The (MDCO)

Open: 23.8200 Day's Range: 23.4530 - 24.2100 Volume: 647,031
Previous Close: 23.5500 52wk Range: 23.2500 - 41.2800 1-Yr Rtn: -22.06%

Stock Chart for MDCO

No chart data available.
  • MDCO:US 24.0900
  • 1D
  • 1M
  • 1Y
23.5500
Interactive MDCO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MDCO

Current P/E Ratio (ttm) 122.9860
Estimated P/E(12/2014) 17.5583
Relative P/E vs. SPX 6.8417
Earnings Per Share (USD) (ttm) 0.1959
Est. EPS (USD) (12/2014) 1.3720
Est. PEG Ratio 1.7558
Market Cap (M USD) 1,566.30
Shares Outstanding (M) 65.02
30 Day Average Volume 575,651
Price/Book (mrq) 1.7483
Price/Sale (ttm) 2.0993
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MDCO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MDCO

The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.

Clive A MeanwellChairman/CEOGlenn P SblendorioPresident/CFO
Victoria KusiakExec VP/Chief Integrity OfcrBrent FurseExec VP/Chief Customer Officer
More Company Profile & Key Executives for MDCO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil